HUP9802431A3 - Pharmaceutical compns. contg. pentosan polysulfate for the treatment of chronic progressive vascular diseases - Google Patents

Pharmaceutical compns. contg. pentosan polysulfate for the treatment of chronic progressive vascular diseases

Info

Publication number
HUP9802431A3
HUP9802431A3 HU9802431A HUP9802431A HUP9802431A3 HU P9802431 A3 HUP9802431 A3 HU P9802431A3 HU 9802431 A HU9802431 A HU 9802431A HU P9802431 A HUP9802431 A HU P9802431A HU P9802431 A3 HUP9802431 A3 HU P9802431A3
Authority
HU
Hungary
Prior art keywords
contg
treatment
vascular diseases
pentosan polysulfate
chronic progressive
Prior art date
Application number
HU9802431A
Other languages
English (en)
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Publication of HUP9802431A2 publication Critical patent/HUP9802431A2/hu
Publication of HUP9802431A3 publication Critical patent/HUP9802431A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU9802431A 1995-06-07 1996-06-03 Pharmaceutical compns. contg. pentosan polysulfate for the treatment of chronic progressive vascular diseases HUP9802431A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/478,347 US5643892A (en) 1995-06-07 1995-06-07 Method of treating chronic progressive vascular diseases
BR9704114-9A BR9704114A (pt) 1995-06-07 1997-07-28 Processo de tratamento de doenças vasculares progressivas crÈnicas

Publications (2)

Publication Number Publication Date
HUP9802431A2 HUP9802431A2 (hu) 1999-02-01
HUP9802431A3 true HUP9802431A3 (en) 2001-06-28

Family

ID=25664870

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9802431A HUP9802431A3 (en) 1995-06-07 1996-06-03 Pharmaceutical compns. contg. pentosan polysulfate for the treatment of chronic progressive vascular diseases

Country Status (14)

Country Link
US (1) US5643892A (hu)
EP (1) EP0809505B1 (hu)
AU (1) AU699012B2 (hu)
BR (1) BR9704114A (hu)
CA (1) CA2210351C (hu)
DE (1) DE809505T1 (hu)
ES (1) ES2115571T3 (hu)
HU (1) HUP9802431A3 (hu)
IL (1) IL121217A (hu)
NO (1) NO313686B1 (hu)
NZ (1) NZ309991A (hu)
TW (1) TW434018B (hu)
WO (1) WO1996040158A1 (hu)
ZA (1) ZA964247B (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010005720A1 (en) * 1995-06-07 2001-06-28 U.S.A. As Represented By The Secretary Department Of Health And Human Services Method of treating chronic progressive vascular scarring diseases
US6255295B1 (en) 1996-12-23 2001-07-03 Nutramax Laboratories, Inc. Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine composition for the protection, treatment, repair, and reduction of inflammation of connective tissue
UA65587C2 (en) 1997-10-09 2004-04-15 Baker Norton Pharma Method for preventing nephrotoxicity induced by cyclosporins or tacrolimus
DE19747195A1 (de) * 1997-10-24 1999-04-29 Knoll Ag Verwendung von Glykosaminoglykanen zur Herstellung von pharmazeutischen Zubereitungen zur Behandlung von mit Diabetes assoziierten Augenkrankheiten
AU2001230994A1 (en) 2000-01-19 2001-07-31 The United States of America, represented by The Secretary, Department of Health & Human Services Use of pentosan polysulfate to treat certain conditions of the prostate
CA2616230A1 (en) * 2005-07-22 2007-02-01 Trf Pharma, Inc. Method for treating sickle cell disease and sickle cell disease sequelae
PT2010220T (pt) * 2006-04-03 2022-05-20 Ceva Animal Health Pty Ltd Formulações de polisulfato de pentosano estabilizado (pps)
US9339524B2 (en) 2009-03-11 2016-05-17 Jellice Co., Ltd. Drug inhibiting the progression of atherosclerosis, preventive drug, blood cholesterol-lowering drug, functional food, and specific health food
WO2011088418A2 (en) * 2010-01-15 2011-07-21 Mount Sinai School Of Medicine Inhibition of tnf-alpha induced activation of nfkb by pentosan polysulfate
CN103764824B (zh) 2011-06-20 2018-04-24 西奈山医学院 粘多糖贮积症和其它溶酶体病症的抗TNF-α疗法
US20130273096A1 (en) * 2011-10-05 2013-10-17 Bruce A. Daniels Therapeutic Sulfated Polysaccharides, Compositions Thereof, and Methods for Treating Patients
EP3842048A4 (en) 2018-08-20 2022-03-30 ReqMed Company, Ltd. NOVEL PENTOSAN POLYSULFATE PREPARATION

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820693A (en) * 1986-05-22 1989-04-11 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
US4966890A (en) * 1986-04-04 1990-10-30 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
DE3725554A1 (de) * 1987-08-01 1989-02-09 Hoechst Ag Pharmazeutisches kombinationspraeparat sowie dessen herstellung und verwendung
US5032679A (en) * 1988-12-15 1991-07-16 Glycomed, Inc. Heparin fragments as inhibitors of smooth muscle cell proliferation
EP0466315A3 (en) * 1990-05-30 1992-07-01 Larrian Gillespie Compositions containing xylan sulphates for affecting growth factor function and for inhibiting fibroblast proliferation
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate

Also Published As

Publication number Publication date
CA2210351C (en) 2003-09-23
IL121217A0 (en) 1999-10-28
AU699012B2 (en) 1998-11-19
WO1996040158A1 (en) 1996-12-19
TW434018B (en) 2001-05-16
EP0809505A1 (en) 1997-12-03
NO973081D0 (no) 1997-07-02
ZA964247B (en) 1996-12-04
HUP9802431A2 (hu) 1999-02-01
NZ309991A (en) 2001-03-30
ES2115571T1 (es) 1998-07-01
DE809505T1 (de) 1998-05-28
NO313686B1 (no) 2002-11-18
EP0809505B1 (en) 2003-04-02
IL121217A (en) 2000-09-28
US5643892A (en) 1997-07-01
EP0809505A4 (en) 1998-07-01
CA2210351A1 (en) 1996-12-19
BR9704114A (pt) 2000-06-06
NO973081L (no) 1997-08-27
AU6030096A (en) 1996-12-30
ES2115571T3 (es) 2003-09-01

Similar Documents

Publication Publication Date Title
CY2436B1 (en) Medicament for treating cardiac inflammatory disease.
EP1029540A3 (en) Use of droloxifene for the treatment of cardiovascular diseases
EP0427588A3 (en) System for the administration of sterile liquids, especially pharmaceutical, nutritive or energetic
AU6311301A (en) Drug/drug delivery systems for the prevention and treatment of vascular disease
HUP9800467A3 (en) Use of hyaluronic acid for producing pharmaceutical compns. for the treatment of interstitial cystitis
AU5263496A (en) Targeted catheter drug administration
HUP9802431A3 (en) Pharmaceutical compns. contg. pentosan polysulfate for the treatment of chronic progressive vascular diseases
ITTO950104A0 (it) Catetere, particolarmente per il trattamento di aritmie cardiache.
ZA968990B (en) Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases.
HK1022432A1 (en) Administration of histamine for therapeutic purposes.
IT1290781B1 (it) Agente attivo terapeutico per il trattamento di malattie degenerative neuronali.
EP0584034A3 (en) Conjugates of cytotoxic drugs for the treatment of neoplastic diseases.
ITTO950099A0 (it) Catetere, particolarmente per il trattamento di aritmie cardiache.
HUP0003256A3 (en) Use of pentosan polysulfate for preparing medicament useful in treating chronic progressive vascular scarring diseases
HUP9901303A3 (en) A pharmaceutical composition for the treatment of autoimmune diseases
NL187299C (nl) Gevormde farmaceutische doseringseenheid voor het behandelen van hart- en vaatziekten.
WO2000043028A3 (en) Method of treating chronic cardiac disease
WO1994018988A3 (en) Use of heparins for the treatment of inflammatory or immunological diseases
HK1005497A1 (en) Use of pentosan polysulfate for the resolution of scars in chronic progressive vascular diseases
ZA991783B (en) Therapeutic treatment for autoimmune diseases.
IT240104Y1 (it) Dispositivo per il trattamento del corpo umano.
OA09832A (en) Pharmaceutical composition for the treatment of protozoal diseases particularly of trypanosomiasis, comprising D-carnitrine or acyl derivative of D-carnitine.
ZA944671B (en) Medicaments for the treatment of inflammatory diseases
AU3651595A (en) Drug for the prevention and treatment of auto-immune and viral diseases, and diagnostic agents for detecting said diseases
GB9109887D0 (en) Pharmaceutical formulations for the treatment of peripheral vascular diseases

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: THE UNITED STATES OF AMERICA, AS REPRESENTED B, US

Free format text: FORMER OWNER(S): BAKER NORTON PHARMACEUTICALS, INC., US

Owner name: IVAX RESEARCH, INC., US

Free format text: FORMER OWNER(S): BAKER NORTON PHARMACEUTICALS, INC., US

FD9A Lapse of provisional protection due to non-payment of fees